These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1650609)
21. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Hass R; Gunji H; Datta R; Kharbanda S; Hartmann A; Weichselbaum R; Kufe D Cancer Res; 1992 Mar; 52(6):1445-50. PubMed ID: 1531783 [TBL] [Abstract][Full Text] [Related]
22. Myeloid differentiation of HL-60 cells induced by anti-tumor drug 3-nitrobenzothiazolo[3,2-a]quinolinium. Baez A; Sepulveda J Leuk Res; 1992; 16(4):363-70. PubMed ID: 1314318 [TBL] [Abstract][Full Text] [Related]
23. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E. Wenzel-Seifert K; Seifert R J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097 [TBL] [Abstract][Full Text] [Related]
24. Induction of the differentiation of synchronized HL-60 leukemia cells by tiazofurin. Sokoloski JA; Blair OC; Carbone R; Sartorelli AC Exp Cell Res; 1989 May; 182(1):234-41. PubMed ID: 2714402 [TBL] [Abstract][Full Text] [Related]
25. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Sarkar R; Gordon D; Stanley JC; Webb RC Am J Physiol; 1997 Apr; 272(4 Pt 2):H1810-8. PubMed ID: 9139967 [TBL] [Abstract][Full Text] [Related]
26. Control of cell differentiation during proliferation. II. Myeloid differentiation and cell cycle arrest of HL-60 promyelocytes preceded by nuclear structural changes. Yen A; Reece SL; Albright KL Leuk Res; 1985; 9(1):51-71. PubMed ID: 3857406 [TBL] [Abstract][Full Text] [Related]
27. Cell cycle dependence of calmodulin levels during HL-60 proliferation and myeloid differentiation. No changes during pre-commitment. Yen A; Freeman L; Powers V; Van Sant R; Fishbaugh J Exp Cell Res; 1986 Jul; 165(1):139-51. PubMed ID: 2940106 [TBL] [Abstract][Full Text] [Related]
29. PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. Lam MH; Olsen SL; Rankin WA; Ho PW; Martin TJ; Gillespie MT; Moseley JM J Cell Physiol; 1997 Dec; 173(3):433-46. PubMed ID: 9369957 [TBL] [Abstract][Full Text] [Related]
30. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells. Schwartz EL; Blair OC; Sartorelli AC Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046 [TBL] [Abstract][Full Text] [Related]
31. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation. Yen A; Varvayanis S Exp Cell Res; 1994 Sep; 214(1):250-7. PubMed ID: 8082728 [TBL] [Abstract][Full Text] [Related]
32. Terminal differentiation of human promyelocytic leukaemia cells, HL-60, during the G1 period. Matsuhisa T Cell Biol Int; 2001; 25(2):185-8. PubMed ID: 11237423 [TBL] [Abstract][Full Text] [Related]
33. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells. Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636 [TBL] [Abstract][Full Text] [Related]
34. Granulocyte functions during maturation of human promyelocytic leukemia cells. Chaplinski TJ; Sloan GJ; Niedel JE Leuk Res; 1985; 9(7):897-903. PubMed ID: 2991670 [TBL] [Abstract][Full Text] [Related]
35. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Lee KW; Kim HJ; Lee YS; Park HJ; Choi JW; Ha J; Lee KT Carcinogenesis; 2007 Sep; 28(9):1928-36. PubMed ID: 17634406 [TBL] [Abstract][Full Text] [Related]
36. In vitro activation of distinct molecular and cellular phenotypes after induction of differentiation in a human neuroblastoma cell line. Gaetano C; Matsumoto K; Thiele CJ Cancer Res; 1992 Aug; 52(16):4402-7. PubMed ID: 1322787 [TBL] [Abstract][Full Text] [Related]
37. Dibutyryl cyclic AMP arrests the growth of cultivated Cloudman melanoma cells in the late S and G2 phases of the cell cycle. DiPasquale A; McGuire J J Cell Physiol; 1977 Dec; 93(3):395-405. PubMed ID: 201651 [TBL] [Abstract][Full Text] [Related]
38. Effect of dibutyryl cyclic AMP on the cyclin-dependent kinase inhibitor p27Kip1 in the human hepatoma cells PLC/PRF/5. Kikukawa M; Okamoto Y; Fukui H; Nakano H Anticancer Res; 1997; 17(5A):3287-91. PubMed ID: 9413161 [TBL] [Abstract][Full Text] [Related]
39. Modulation of apoptosis of proliferating and differentiating HL-60 cells by protein kinase inhibitors: suppression of PKC or PKA differently affects cell differentiation and apoptosis. Savickiene J; Gineitis A; Stigbrand T Cell Death Differ; 1999 Jul; 6(7):698-709. PubMed ID: 10453081 [TBL] [Abstract][Full Text] [Related]
40. Comparative effects of butyrate and N6, 2'-O-dibutyryladenosine-3':5'-cyclic monophosphate on growth, differentiation and gene expression in U937 human monoblastoid cells. Rius C; Zorrilla A; Mata F; Aller P Biochem Int; 1991 Feb; 23(3):555-62. PubMed ID: 1652247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]